Tenofovir vs. Entecavir after treatment for HBV-associated HCC

Published Date: 08 Mar 2023

This review compared the effectiveness of entecavir and tenofovir in reducing relapses and mortality after treatment for HBV-related hepatocellular carcinoma.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Unified Neuro/Psych Residency Program: New Proposal.

2.

Medical Journal March 29, 2023

3.

improvements in the treatment of prostate cancer resistant to chemotherapy.

4.

Upfront TKI for Bone-Predominant RCC Tops Single-Agent Immunotherapy

5.

Liver cancer cells under pressure: Compression can spark invasion, drug resistance and altered gene activity


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot